Vivus Wins Its First Fda Drug Approval

The FDA approved a drug to treat erectile dysfunction from Vivus that would compete against Viagra, Cialis and Levitra.

Topics:  fda   vivus   viagra   cialis   levitra   drug   
  • Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day
    Vivus has been pushing for more than two years to get its new obesity drug cleared for sale by the FDA, and after one last long, confusing day, it finally got its wish. The FDA said today that the Mountain View, CA-based company (NASDAQ: VVUS) has gotten ...
    07/17/2012 - 12:35 pm | View Link
  • Vivus Wins FDA Approval
    MINYANVILLE ORIGINAL Vivus (VVUS) shareholders got a piece of good news late last week when the Food and Drug Administration approved the ... a decision on market clearance in April but the FDA delayed doing so until July 17. "The majority of the value ...
    04/30/2012 - 9:36 am | View Link
  • Vivus' Erectile Dysfunction Drug Stendra Wins FDA Approval
    Law360, New York (April 27, 2012, 8:00 PM ET) -- The U.S. Food and Drug Administration on Friday approved Vivus Inc.'s erectile dysfunction pill Stendra, the first erectile dysfunction treatment to be allowed for use in the U.S. in a decade and the first ...
    04/27/2012 - 1:00 pm | View Link
  • Vivus Obesity Pill Wins FDA Panel Nod; NeuroSearch Surges
    won FDA clearance in 2007 as the first diet drug available without a prescription. To contact the reporter on this story: Anna Edney in Washington at To contact the editors responsible for this story: Adriel Bettelheim at abettelheim@ ...
    02/23/2012 - 3:23 am | View Link
  • Vivus' Weight-Loss Drug Faces Key U.S. Test
    If Qnexa wins the FDA's green light, that could more than double. Analysts estimate Vivus' drug could take in nearly $689 million in sales by 2014, according to consensus forecast data from Thomson Reuters. It would be the second U.S. drug for the biotech ...
    07/14/2010 - 1:00 pm | View Link
  • More
  • Vivus
    View detailed financial information, real-time news, videos, quotes and analysis on Vivus (NASDAQ:VVUS). Explore commentary on Vivus and hear what the experts at ...
    10/10/2015 - 1:39 am | View Website
  • BioWorld | The Daily Biopharmaceutical News Source
    Contains business, science, and regulatory news, including mergers and collaborations, FDA hearings and results, and research breakthroughs. Need subscription to use.
    10/9/2015 - 8:14 am | View Website
  • Orgasm Inc. (2009)
    Share this Rating. Title: Orgasm Inc. (2009) 6 /10. Want to share IMDb's rating on your own site? Use the HTML below.
    10/7/2015 - 11:25 pm | View Website
  • News | Catalent
    10/01/2015 Catalent Launches Optiform® Solution Suite For Accelerated Drug Development . 09/28/2015 Catalent Quality Expert Invited To Discuss Effective Auditing ...
    10/7/2015 - 1:02 pm | View Website
  • Regulatory
    China's MicroPort earned the FDA's most serious designation over a recall of devices used in hip joint replacement surgery after reports surfaced that showed the ...
    10/7/2015 - 7:19 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News